GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » American Green Inc (OTCPK:ERBB) » Definitions » Debt-to-EBITDA

American Green (American Green) Debt-to-EBITDA : -206.05 (As of Jun. 2023)


View and export this data going back to . Start your Free Trial

What is American Green Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

American Green's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $22.81 Mil. American Green's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.47 Mil. American Green's annualized EBITDA for the quarter that ended in Jun. 2023 was $-0.11 Mil. American Green's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 was -206.05.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for American Green's Debt-to-EBITDA or its related term are showing as below:

ERBB' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -206.05   Med: -206.05   Max: -206.05
Current: -206.05

During the past 2 years, the highest Debt-to-EBITDA Ratio of American Green was -206.05. The lowest was -206.05. And the median was -206.05.

ERBB's Debt-to-EBITDA is ranked worse than
100% of 659 companies
in the Drug Manufacturers industry
Industry Median: 1.71 vs ERBB: -206.05

American Green Debt-to-EBITDA Historical Data

The historical data trend for American Green's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Green Debt-to-EBITDA Chart

American Green Annual Data
Trend Jun22 Jun23
Debt-to-EBITDA
- -206.05

American Green Semi-Annual Data
Jun22 Jun23
Debt-to-EBITDA - -206.05

Competitive Comparison of American Green's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, American Green's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Green's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, American Green's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where American Green's Debt-to-EBITDA falls into.



American Green Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

American Green's Debt-to-EBITDA for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(22.812 + 0.472) / -0.113
=-206.05

American Green's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(22.812 + 0.472) / -0.113
=-206.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (Jun. 2023) EBITDA data.


American Green  (OTCPK:ERBB) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


American Green Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of American Green's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


American Green (American Green) Business Description

Traded in Other Exchanges
N/A
Address
30 N Gould Street, Suite R, Sheridan, WY, USA, 82801
American Green Inc is a technology company in the medical cannabis industry. It is involved in the business of developing a cultivation facility in Phoenix Arizona for medical marijuana and also owns proprietary dispensing machines and all rights to a line of health supplements.